Cancer vaccines are one of the most important methods of cancer immunotherapy. The three main factors that determine the efficacy of cancer vaccines are antigen, adjuvant, and formulation. Antigens induce specific immuneRead More…
According to WHO data, since the identification of the cause of acquired immunodeficiency syndrome (AIDS) in 1984, the human immunodeficiency virus (HIV) has infected more than 80 million people and caused 40Read More…
Recently, SCIENCE CHINA Life Sciences published a collaborative research paper entitled “Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity”. In this study,Read More…
Monkeypox, a zoonotic disease, was first found in monkeys used in the study in 1958 and spread mainly in animals. Human monkeypox cases were first found in the Democratic Republic of theRead More…
GSK announced that its respiratory syncytial virus (RSV) vaccine Arexvy (RSVPreF3 OA/GSK3844766A) has been approved by the FDA for the prevention of lower respiratory disease (RSV-LRTD) caused by RSV infection in theRead More…
Therapeutic tumor cells (ThTCs) are expected to become a new class of anticancer drugs because they naturally carry new tumor antigens. This strategy has been proven to induce an anti-tumor immune responseRead More…
Monkeypox virus (monkeypox, MPXV) was first identified in non-human primates in the late 1950s. Monkeypox, a zoonotic disease, was first found in monkeys used in the study in 1958 and spread mainlyRead More…
Therapeutic tumor cells (ThTC) are expected to become a new class of anticancer drugs because they naturally carry new tumor antigens. This method has been shown to trigger the transfer of powerfulRead More…
Tumor vaccine is the use of tumor antigen to cause the body to create particular anti-tumor effect, activate the body’s own immune defense mechanism, and achieve the function of tumor therapy orRead More…
In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania found that an experimental mRNA vaccine against all 20 known influenza virus subtypes provides extensive protectionRead More…